SCHEMBL17878489

SCHEMBL17878489

CC1(C)OB(c2cccc(-c3cccc(N(c4ccccc4)c4ccc5ccccc5c4)c3)c2)OC1(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 9/20 0.54
LPL P06858 8/20 0.54
IRAK4 Q9NWZ3 1/20 0.34
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
DGAT1 O75907 1/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
SLC6A4 P31645 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
P4HB P07237 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17878483 0.92 LIPG (0.52) LIPGLPLIRAK4MTNR1AMTNR1B
SCHEMBL29450796 0.92 LIPG (0.52) LIPGLPLIRAK4MTNR1AMTNR1B
SCHEMBL17878484 0.92 LIPG (0.52) LIPGLPLIRAK4MTNR1AMTNR1B
SCHEMBL29450797 0.92 LIPG (0.52) LIPGLPLIRAK4MTNR1AMTNR1B
SCHEMBL28951694 0.92 LIPG (0.64) LIPGLPLIRAK4DGAT1CHRNA1
SCHEMBL17878513 0.91 LIPG (0.53) LIPGLPLIRAK4DGAT1P4HB
SCHEMBL20964185 0.91 LIPG (0.53) LIPGLPLIRAK4DGAT1P4HB
SCHEMBL16383444 0.90 LIPG (0.56) LIPGLPLIRAK4DGAT1P4HB
SCHEMBL17878490 0.90 LIPG (0.55) LIPGLPLIRAK4DGAT1P4HB
SCHEMBL17878499 0.89 LIPG (0.57) LIPGLPLIRAK4DGAT1P4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957441-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-01 US disclosed
US-9957441-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-01 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, TYR, TAAR1 LIPG 3199/4885LPL 2918/4885IRAK4 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.